Nanobodies (Nbs) are popular and versatile tools for structural biology because they have a compact single immunoglobulin domain organization. Nbs bind their target proteins with high affinities while reducing their conformational heterogeneity, and they stabilize multi-protein complexes. Here we demonstrate that engineered Nbs can also help overcome two major obstacles that limit the resolution of single-particle cryo-EM reconstructions: particle size and preferential orientation at the water-air interface. We have developed and characterised novel constructs, termed megabodies, by grafting Nbs into selected protein scaffolds to increase their molecular weight while retaining the full antigen binding specificity and affinity. We show that the megabody design principles are applicable to different scaffold proteins and recognition domains of compatible geometries and are amenable for efficient selection from yeast display libraries. Moreover, we used a megabody to solve the 2.5 Å resolution cryo-EM structure of a membrane protein that suffers from severe preferential orientation, the human GABA A b3 homopentameric receptor bound to its small-molecule agonist histamine.
INTRODUCTION
Single particle cryo-EM has recently become the technique of choice for the structural characterisation of membrane proteins and macromolecular complexes [1] [2] [3] . Instrumentation and data analysis methods continue to improve at a spectacular pace 4, 5 . However, factors including small particle size, low symmetry, high flexibility and non-random distribution in ice limit the achievable resolution of 3D reconstructions. Whereas large molecules are relatively easy to identify in noisy low-dose images of frozen hydrated samples, and have sufficient features to facilitate the accurate determination of their orientation and position required for alignment and averaging 6 , structural analysis of small particles (~100 kDa or less) is considerably more difficult. Phase contrast methods such as defocusing the objective lens or the use of phase plates, especially the Volta phase plate (VPP) 7 , enable imaging of biological specimens with an acceptable (albeit still limiting) amount of radiation damage 8 . Despite the recent success in high-resolution reconstructions of small macromolecule proteins aided by a VPP including streptavidin (52 kDa tetramer, ~3.2 Å) 9 and human haemoglobin (64 kDa tetramer, ~3.2 Å) 10 or using conventional defocus-based data collection for methaemoglobin (64 kDa tetramer, ~2.8 Å and ~3.2 Å) and alcohol dehydrogenase (82 kDa dimer, ~2.7 Å) 11 , the routine analysis of such samples remains very challenging. To circumvent this problem, several protein engineering approaches have been employed to increase the size of particles. Small proteins have been genetically fused to scaffold proteins in order to increase their size directly 12 or bound to recognition domains organised in a large molecular support of high symmetry 13, 14 . Attempts to align the target molecules according to the symmetry of a multimeric scaffolds, with the help of local/focused classification techniques, are useful in principle but in practice limited by the flexibility of linker regions.
Regardless of particle size, their distribution in the thin ice layer greatly impacts on the quality and resolution of resulting cryo-EM maps 15 . The idea that particles are randomly oriented in ice after grid blotting and rapid cryo-plunging is far from the experimental reality. During the vitrification process, particles diffuse and interact with the water-air and/or water-support interfaces even 1000 times a second 15, 16 . This can lead to protein denaturation but also, in almost all instances, particles are adsorbed to such interfaces and present preferential orientation due to their surface properties 17 . While supplementation of buffers with surfactants such as detergents is often employed to improve particle distribution in ice 18 , for sensitive specimens including membrane proteins this approach should be avoided. To limit the impact of preferential particle orientation, specimens can be tilted inside the microscope during data collection 19 . Additionally, faster plunge-freezing devices that reduce the time between sample application and vitrification 20 , utilization of graphene-supported grids with tuneable surface properties 21 or engineered hollow 3D-DNA structures able to trap DNA-binding proteins inside the scaffold 22 are also being explored. Yet, to date, such approaches could not be generalised to eliminate the particle orientation problem in cryo-EM.
To help overcome these performance barriers, we designed a novel class of chimeric molecules, called megabodies (Mbs). Megabodies are built by grafting single domain antigen-binding constructs such as nanobodies (~15 kDa) 23, 24 or monobodies (~10 kDa) 25 , into larger scaffold proteins to produce stable, reasonably rigid and efficiently-folding monomeric chimeras. The generic nature of this technology enables a direct selection of novel megabodies directly from nanobody immune libraries or, alternatively, a straightforward reformatting of existing nanobodies. We show that megabodies, unlike their parental nanobodies, successfully overcome the severe preferential orientation of a relatively small (~200 kDa) membrane protein, the human GABA A -b3 receptor reconstituted in a lipid nanodisc. The excellent quality of the cryo-EM map obtained, to 2.5 Å resolution, allows unambiguous identification and refinement of histamine, a small-molecule agonist composed of only eight non-hydrogen atoms.
RESULTS

Design, expression and purification of megabodies
The generic megabody design consists of a small globular domain, such as a nanobody, grafted into a scaffold protein via two short peptide linkers ( Fig. 1a, b ). As proofs of principle, we designed synthetic genes encoding megabodies build from a GFP-specific nanobody (Nb207, Supplementary Table 1 ) that is linked through its first loop (connecting β-strands A and B) to an exposed β-turn of selected scaffold proteins. We have identified two secreted bacterial proteins containing antiparallel β-strands with surface accessible β-turns: β-turn S3-S4 of the adhesin domain of H. pylori 26 (HopQ, 45 kDa, PDB ID: 5LP2, Supplementary Fig. 1a -c) and β-turn A'S1-A'S2 of the E. coli K12 Glucosidase YgjK 27 (YgjK, 86 kDa, PDB ID: 3W7T) ( Supplementary Fig. 1d-e ). Accordingly, we grafted Nb207 into circular permutants 28 of these molecular scaffolds to build megabodies Mb Nb207 cHopQ ( Fig. 1c) and Mb Nb207 cYgjKE2 of about 56 and 100 kDa, respectively ( Supplementary Fig. 2 ). These chimeric proteins were next produced as highly soluble proteins in the periplasm of E. coli and purified in milligram quantities ( Supplementary Fig. 2f, g Fig. 2h ). In our experience, these megabodies also resist at least two freezethaw cycles.
To assess the structural impact of the proposed fusion scheme, we grew diffracting crystals of both megabodies. Although attempts to obtain a structure of Mb Nb207 cYgjKE2 failed so far, partly due to poor diffraction (~5 Å), we solved the crystal structure of Mb Nb207 cHopQ to 2.8 Å resolution ( Fig.   1b, Supplementary Fig. 3, Supplementary Fig. 4 , Supplementary Table 2 ). The Mb Nb207 cHopQ crystallised in the space group P1 containing ten molecules in the asymmetric unit (PDB ID: 6QD6). The two short peptide linkers connecting the nanobody and the scaffold are welldefined in the electron density map, except for molecule J, where the first twelve residues of the megabody were not visible. The ten molecules in the asymmetric unit superimpose with low root mean square deviations (RMSD) in a range from 0.557 to 3.341Å (for 1-532 equivalent C α positions refined in the electron density), mainly caused by the nanobody-scaffold linker flexibility which allows a maximal relative rotation of 22.2° when measured between molecules Fig. 3d ). The circular permutation and the insertion of the nanobody between β-strands S3 and S4 of HopQ does not affect the overall tertiary structure of this scaffold protein ( Supplementary Fig. 4 ). The elongated shape of Mb Nb207 cHopQ revealed by crystallography is in agreement with small angle X-ray scattering (SAXS) analysis performed in solution, where the crystallography-based theoretical scattering profile yielded overall good fit to the experimental data ( Supplementary Fig. 5 , discrepancy χ 2 SAXS in a range from 1.699 to 2.033 for molecule B and E, respectively). Most importantly, Nb207 and both its enlarged variants, Mb Nb207 cHopQ and Mb Nb207 cYgjKE2 bind their cognate antigen GFP with similar affinities ( Supplementary Fig. 6 ), which confirms that the binding properties of the parental nanobody are not affected by insertion into different scaffolds according to Fig. 1a .
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To verify whether the same design principles are not restricted to nanobodies but can also be applied to other antigen-binding domains, we enlarged the small monobody NS1 that binds to both GTP-and GDP-bound states of H-RAS and K-RAS 29 . Monobodies are engineered derivatives of the fibronectin type III domain fold, composed of a seven-stranded β-sandwich built from one three-and one four-stranded β-sheet 25 (Supplementary Fig. 7c ). The megabody Mb NS1 cHopQ was generated by the insertion of the cHopQ scaffold into the first β-turn (connecting β-strands A and B) of the monobody NS1 ( Supplementary Fig. 7d, e ). Antigen binding was confirmed by measuring binding of fluorescently labelled K-RAS using yeast surface display and flow cytometry 30 (Supplementary Fig. 7f ).
Selection of megabodies from nanobody-immune libraries by yeast display
The complementarity-determining regions (CDRs) which determine the specificity of a given nanobody, are encoded by three hypervariable regions (HV), whereas four more conserved framework (FR) regions define the tertiary structure by encoding nine β-sheets 23, 31 ( Supplementary Fig. 8a ). Building on the structural conservation of the immunoglobulin fold, we found that any given nanobody can easily be reformatted into a megabody of choice by substituting the nanobody sequence, once the connecting linkers between one representative nanobody and a particular scaffold protein are defined. Furthermore, we hypothesised that in vivo matured nanobody immune libraries can be cloned as megabody display libraries and screened by conventional phage display or yeast display for the direct selection of functional megabodies. To test this concept, we amplified the open reading frames of the nanobody repertoire of a GFP-immunised llama, lacking the 5'-end that encodes a highly conserved βstrand A. These fragments were cloned in a yeast display vector according to Fig. 2a using the same sequence for β-strand A and the same peptide linkers to fuse nanobody to cHopQ as in Mb Nb207 cHopQ described above ( Fig. 2a, Supplementary Fig. 8 ). The generated megabody library was displayed on yeast cells in frame with the Aga2p anchor protein followed by an acyl carrier protein (ACP) for orthogonal labelling 30 (Fig. 2b) . This approach enables the identification and subsequent sorting of yeast cells that display high levels of a particular megabody (high DY-647P1 fluorescence) and bind the cognate antigen (high GFP fluorescence) ( Fig. 2c) . After three rounds of selection, nine novel GFP-specific megabodies were identified ( Supplementary Fig.   8 ), demonstrating that antigen-binding chimeric proteins can be selected from displayed megabody libraries assembled from llama immune libraries in a straightforward manner.
Megabodies randomize the orientation of GABA A receptor particles in ice and enable high resolution cryo-EM reconstructions GABA A receptors (GABA A Rs) are pentameric ligand-gated ion channels (pLGICs), which mediate fast inhibitory signalling in the human brain and are targets for clinically-relevant drugs including benzodiazepines and general anaesthetics 32 . In single particle cryo-EM, GABA A Rs and related pLGICs are known to suffer from severe preferential orientation in free-standing ice unless detergents are added to the samples. Although such approach in combination with Fab antibody fragments enabled structural analyses of heteromeric GABA A receptors by cryo-EM 33, 34 , the presence of detergents damaged the integrity of transmembrane domains (TMDs) and of the interfaces between TMDs and extracellular regions 35 .
To assess the utility of megabodies for single particle cryo-EM and to enable structural studies of human GABA A Rs in lipid bilayers, we enlarged nanobody Nb25, which interacts with the extracellular domain (ECD) of the GABA A R b3 subunit 36 to two megabody variants, Mb Nb25 c7HopQ and Mb Nb25 cYgjKE2 , following the same reformatting principals used for Nb207 ( Supplementary   Fig. 2a-c) . We inserted a GABA A R-b3 37 homomeric receptor construct into lipid nanodiscs using "on-beads" reconstitution 38, 39 and subsequently vitrified these particles on electron microscopy grids alone or in complex with Nb25, Mb Nb25 c7HopQ or Mb Nb25 cYgjKE2 . We collected and analysed small cryo-EM datasets for these samples in order to evaluate the extent of preferential particle orientation in each condition ( Fig. 3) . Firstly, when GABA A R-b3 homomer samples were frozen alone, ~84% of the particles observed had their five-fold symmetry axis perpendicular to the water-air interface ("top" views, Fig. 3a ). Addition of Nb25 did not improve particle orientation (Fig. 3b) . In both cases, 3D reconstruction attempts led to severely anisotropic maps with large missing regions and low particle distribution efficiencies 15 (E od = 0.18 and 0.22, respectively) ( Fig. 3a,b ). Remarkably however, more than ~77% of classified particles displayed different orientations ("tilted" views) when the GABA A R-b3 receptor was bound to Mb Nb25 c7HopQ (Fig. 3c) . This in turn allowed the reconstruction of a 3D map with a threefold higher angle distribution efficiency (E od = 0.76) and mostly isotropic features. In contrast, Mb Nb25 cYgjKE2 had an opposite effect and induced almost exclusively "top" GABA A R-b3 views which led to the most anisotropic 3D reconstruction ( Fig. 3d) . Megabodies therefore can directly affect the orientation of particles in ice, however it is clear that multiple megabody variants, with different scaffolds, should be tested for a protein of interest.
Based on these findings, we extended this approach to enable cryo-EM studies of the major human heteromeric GABA A R variant a1b3g2. Unlike the homomeric GABA A R-b3 37 , heteromeric receptor versions, especially in a physiologically meaningful lipid environment, are intractable for structural analysis by X-ray crystallography. We enlarged the nanobody Nb38 that binds a1 subunits between non-adjacent ECD interfaces 40 to generate the megabody Mb Nb38 cHopQ , which enabled high-resolution cryoEM structures of the full-length a1b3g2 human GABA A R in lipid nanodiscs bound to a series of small molecule modulators including the competitive antagonist bicuculline, the channel blocker picrotoxin, the agonist GABA and the classical benzodiazepines alprazolam (Xanax) and diazepam (Valium), respectively 38, 39 .
Histamine binding mode and conformational impact on the GABA A R-b3 homomer
The Mb Nb25 c7HopQ megabody allowed us to solve a 2.49 Å resolution cryo-EM structure of the GABA A R-β3 homopentamer bound to its agonist histamine 41 ( Fig. 4, Supplementary Fig. 9 - Fig.12 ). However, the high resolution and excellent quality of the cryo-EM map enabled straightforward model building and refinement as well as unambiguous identification of the histamine density, a molecule composed of only eight non-hydrogen atoms.
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Histamine occupies all five canonical agonist pockets under the sensor loop-C ( Fig. 4c, d , Supplementary Fig. 11d ). The imidazole ring of histamine points towards the complementary (β3 -) side of the pocket where it is stacked between the side chains of Phe200 and Tyr62 and forms a hydrogen bond with Asp43 side chain ( Fig. 4e, f) . The histamine ethylamine group faces the principal (β3 + ) side of the pocket and forms hydrogen bonds with the Glu155 side chain and backbone carbonyls of Ser156 and Tyr157, and a cation-p interaction with the aromatic ring of Tyr205 ( Fig. 4e, f) . As expected for a GABA A R agonist, histamine binding induces closure of the sensor loop-C and an anti-clockwise rotation of each subunit ECD relative to its corresponding TMD, reminiscent to the impact of benzamidine on the GABA A R-β3 homopentamer 37 and GABA on the α1β3γ2L GABA A R hetermomeric receptor 39 ( Supplementary Fig. 10 ). The GABA A R-β3 channel pore is in a desensitised conformation, with the 9'Leu activation gate open and the -2' desensitization gate closed, a conformation reminiscent of the benzamidine-bound crystal structure solved in detergent 37 (Fig. 4g) .
However, unexpectedly, the upper half of the pore is relatively narrower, perhaps reflecting the impact of the lipid environment in which the GABA A R-β3 construct described here was reconstituted.
CONCLUSIONS
We describe here the generic megabody technology, which allows the rapid reformatting, or direct library selection, of high affinity binding domains such as nanobodies or monobodies into larger, conformationally and functionally stable chimeras. We illustrate this technology by using two scaffold proteins, but the same design principle can be applied to any scaffold of any size or geometry required to avoid sterical clashes with the target, providing that it contains a rigid β-hairpin loop that tolerates globular domain insertions. This simple but powerful approach expands the nanobody toolkit for protein structure determination by single-particle cryo-EM but also, at least theoretically, X-ray crystallography because the relatively large and rigid scaffolds themselves offer novel opportunities for crystal contacts. The primary benefit of megabodies in cryo-EM is indeed the ability to randomise the particle distribution in ice for very difficult membrane protein samples, such as pLGICs, that normally exhibit severe preferential orientation. We found cHopQ-based megabodies to be very efficient tools for homomeric and heteromeric GABA A receptors, however the same nanobodies built into a cYgjKE2 scaffold did not help in this case. Therefore, it is possible that the optimal megabody scaffold will vary for other target proteins as well.
Besides the impact on particle orientation we report, the megabodies (~56 kDa and ~100 kDa) also facilitate the in silico "purification" 42 of particles, sorting those that contain the stable antigen:megabody complex from those that contain the antigen only or other contaminants.
When the nanobody recognition domain is specific to a particular conformation of the target protein, this particle classification step will ensure that the 3D reconstruction obtained represents the antigen in the particular state trapped by the megabody. The increased particle size of antigen:megabody complexes can also facilitate their identification and picking from low-contrast micrographs. Most importantly, the megabody technology has the potential to further stimulate the rapidly growing field of drug discovery using single particle cryo-EM 43 
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and FACS. Plasmid pNMB2 is a derivative of yeast surface display vector pNACP 30 . A new display cassette encoding the following elements was synthesised and cloned as an EcoRI-BglII fragment to replace the original cassette: appS4 leader sequence (LS) for secretion 61 , followed by a consensus sequence encoding the conserved β-strand A of the nanobody fold 44 (residues 1-14 in IMGT numbering, QVQLVESGGGLVQ), the C-terminal part of HopQ 26 (residues 227-449, UniProtKB B5Z8H1), a short peptide linker ASGGGSGGGGSG connecting the Cterminus and the N-terminus of HopQ to produce a circular permutant of the scaffold protein, the N-terminal part of HopQ (residues 49-221, UniProtKB B5Z8H1), a multi cloning site (MCS), the Aga2p anchor protein followed by the Acyl Carrier Protein (ACP) and the Myc tag ( Fig. 2a) . The parental cloning vector pNMB2 encodes an in frame stop codon in the MCS to avoid background display and orthogonal staining of ACP from plasmids that do not contain an insert.
A llama was immunised with GFP+ 58 and mRNA fragments encoding the full collection of the naturally circulating nanobody repertoire of the immunised animal were isolated as described 24 .
Briefly, total RNA was isolated from the peripheral blood lymphocytes (PBLs) of the immunised animal to prepare cDNA and the open reading frames encoding all immunoglobulin heavy-chains were amplified by RT-PCR with primers call001 and call002. Fragments encoding the nanobodies from β-strands B to G were amplified thereof through a nested PCR using primers TU64 and TU65 ( Fig. 2a, Supplementary Fig. 8, Supplementary Table 4 ). 10
µg of this PCR product was mixed with 10 µg of BamHI/HindIII linearised pNMB2 and transformed into electrocompetent EBY100 Saccharomyces cerevisiae cells for GAP repair homologous recombination 62 to produce a library of yeast cells that display diverse cHopQ megabodies derived from the nanobody repertoire of a GFP-immunised llama.
This yeast library displaying diverse megabodies was inoculated, induced and orthogonally stained with CoA-647 to monitor the display level of the Mb-Aga2p-ACP fusion on each yeast cell as described 30 . In each round of selection, 4 × 10 7 of these stained yeast cells were incubated with GFP for 60 min at 4 °C in 500 µl of cold PBS supplemented with 0.2% (w/v) BSA at pH 7.4 (PBS-BSA). Yeast cells were next washed three times with and resuspended in 2 ml of PBS-BSA and sorted on a FACS Aria (BD Biosciences). Selected yeast cells were recovered into SDCAA medium, grown and induced, then stained again for subsequent rounds of selection. Individual yeast clones expressing a GFP binding megabody were grown separately in 96-well plates for sequencing and further characterisation as described 30 . Briefly, each clone was confirmed to become green fluorescent after incubation with 100 nM GFP followed by 3 wash steps by flow cytometry using FACS Fortessa (BD Biosciences). Routinely, ~10,000 yeast cells derived from a particular clone were analysed to calculate the GFP mean fluorescence intensity (MFI) using FlowJo software (FlowJo, LLC) and compared to the fluorescence of a yeast clone displaying an irrelevant megabody as the negative control.
Expression and purification of Nb25, Mb Nb25 c7HopQ and Mb Nb25 cYgjKE2 . Nb25 was expressed and purified as described before 36 . pMESD2c7 is a variant of cloning vector pMESD2 in which the C-terminal end of HopQ scaffold protein (residues 227-446, UniProtKB B5Z8H1) is directly fused to its N-terminal end (residues 53-221, UniProtKB B5Z8H1) omitting the additional flexible linker to implement circular permutation. We constructed this alternative circular permutation variant of HopQ (c7HopQ) because the linker used to design our first megabody (Mb Nb207 cHopQ ) was flexible and not visible in the electron density maps (PDB ID: 6QD6). The gene fragment encoding β-strands B to G of the β3 GABA A R-specific Nb25 36 (residues 18-128 in IMGT numbering) was amplified by PCR using primers TU89/EP230 ( Supplementary Table   4 ) and cloned as a SapI fragment into pMESD2c7 or pMESP3E2 to produce pMESD2c7_Mb Nb25 c7HopQ and pMESP3E2_Mb Nb25 cYgjKE2 , respectively. All Nb25-derived megabodies were expressed and purified as described above.
Expression of human b3 homopentameric GABA A R. A human b3 homopentameric GABA A R (UniProtKB P28472) construct which contains the K279T point mutation for increased stability, an SQPARAA linker 32 substituting the M3-M4 loop, and a C-terminal (GGS) 3 GK-Rhodopsin-1D4-tag (TETSQVAPA) 63 was transiently expressed in HEK293S-GnTIcells as described 37 . Briefly, HEK293S-GnTIcells were grown in protein expression medium (PEM, Thermo Fisher Scientific) supplemented with 1% foetal bovine serum (Invitrogen) at 37 °C, 8% CO 2 . Cells were transfected with the DNA-PEI mix at a ~2×10 6 cells/ml density, and 48 h post-transfection were harvested by centrifugation at 4,000g, 4 °C.
Cell pellets were snap-frozen in liquid N2 and stored at -80 °C for future use. Supplementary Table 3 .
Nanodisc reconstitution of human
In order to investigate the proportion of preferential particle views of b3 GABA A R particles in samples where b3 homomer was alone or complexed with Nb25, Mb Nb25 c7HopQ or Mb Nb25 cYgjKE2 , small cryo-EM datasets were analysed by using the same basic data processing procedure. First, MotionCor2 65 was used to motion-correct the movies and Warp 66 was applied to estimate the contrast transfer function (CTF), phase shift parameters and to pick, and extract particles. The reference-free 2D classification was performed using RELION 3.0 67 . One round of 2D classification was performed and well-aligned 2D classes showing clear GABA A R particle projections were used to determine the proportion of preferred particle orientations in each sample (around 6,000 particles for each of the conditions). Next, the particles from the 2D classification were subjected to reference-free 3D model generation and 3D refinement using cryoSPARC 68 . The efficiency of the particle orientation distribution (E od values) for each 3D model was calculated using cryoEF 15 .
For the high-resolution reconstruction of b3 GABA A R bound to Mb Nb25 c7HopQ , a larger dataset was processed using RELION 3.0 as described below. MotionCor2 and Gctf 69 wrappers inside RELION 3.0 package were used to motion-correct movies and to estimate the contrast transfer function and phase shift parameters, respectively. Manual inspection was used to discard poor quality movies. Next, particles were auto-picked using a Gaussian blob autopicker function in RELION 3.0. The resulting particles were 2D classified and the best classes were selected for further processing. Stochastic gradient descent (SGD) methodology 68 (RELION 3.0) was used to generate an initial reference-free 3D model. A 'gold standard' 3D-refinement was performed and subjected to Bayesian particle polishing 70 . Next, particles were sorted using 3D classification jobs without particle alignment and the highest-resolution classes were used for a 3D-refinement using a soft mask and solvent-flattened Fourier shell correlations (FSCs). Figure 9 ). Local map resolution was estimated with ResMap 71 .
For atomic model generation, the coordinates of β3 GABA A R (PDB ID: 4COF) and a5b3 chimera (PDB ID: 5O8F) bound to Nb25 were used as templates. First, the atomic coordinates of b3 homomer ECD, TMD and Nb25 were fitted to the highest resolution map (2.49 Å) as rigid bodies using UCSF Chimera. Then, the coordinates were manually adjusted using COOT 50 followed by several rounds of global refinement and minimisation in real space with phenix_real_space_refine 72 . The geometry constraint files for histamine molecule were generated using Grade Web Server (Global Phasing). The model geometry quality assessment was performed using the MolProbity 51 web server. To validate the refinement protocol, the coordinates of the final model were displaced by 0.5 Å using CCP-EM software 73 . The resulting model was refined with phenix_real_space_refine against one of the half-maps produced by RELION 3.0. FSC curves were calculated between this model and the half-map used for refinement ('work') and the half-map, which was not used for refinement, ('free') using phenix.mtriage 74 . In addition, the FSC curve was calculated for the refined model vs the final sharpened map ('full'). The separation between FSC work and FSC free curves was not significant, indicating the model was not over-refined. Pore diameters were calculated using the HOLE 75 plug-in available in Coot. Fig. 5 ) is a derivative of yeast surface display vector pNACP 30 encoding the following elements: appS4 leader sequence (LS) 61 , β strand A of monobody NS1 29 Fig. 7) .
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Yeast cells containing pNS1MB vector were inoculated and orthogonally stained with CoA-488 to monitor the display level of the Mb NS1 cHopQ -Aga2p-ACP fusions as described 30 
